Delivery Order SPE2DB22D1041-SPE2DB25FUAJ7

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,653.06 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a performance period through May 2, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,602.25, is for the provision of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract has a ceiling value of $2,388.66 and a completion date of May 25, 2023. It is a firm fixed-price contract classified as a delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This contract is part of a larger Indefinite Delivery...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,050.98 contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical that serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, valued at $38,073.44, for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,247.15, is for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. The contract has a period of performance through March 19, 2025 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,318.69, is for the supply of 4,560,696,224 units of the pharmaceutical product SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has an ultimate completion date of April 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4 gram packages, with a total ceiling value of $1,668.24 and a period of performance through March 3, 2025. The contract is an open competition award, with no set-aside designation. AmerisourceBergen holds a significant...
This contract represents a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.56, is for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4 gram quantity. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,663.96, is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FUAJ7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,275.83, is for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and is open to full and open competition.

Generated 7/18/25, 9:55 AM